You have been working in the life science and healthcare sector for more than fifteen years. What makes this work so appealing?
The sector has its own special challenges. On the one hand, the costs for drug development are significant and the development itself is highly regulated...
Is there a problem with increasing life expectancy? If you look at the graph of average life years alone, the development over the last fifty years looks very positive. This graph shows a steady upward trend, especially in Western countries. People are getting older continuously.
There is, however, a second graph that has risen much slower: that of healthy life expectancy...
Do you remember first hearing about MetrioPharm?
Yes, I do remember. I have a friend, who told me to take a look at this company. I reviewed their data and the first thing I liked was the unique profile of the MP1032 platform...
Timetables on the office walls, e-mails with long to-do lists and meetings of all project groups: The new year has started off busy. In order to move the MetrioPharm pipeline ahead as planned, the team is coordinating several major projects simultaneously.
One of the most important is the completion of the Phase II trial in the indication psoriasis...
The founders from left to right: Dr.Wolfgang Brysch, Rudolf Stäger and Ekkehard Brysch, Foto: © Eva Brysch
In spring 2018, we met the three founders of MetrioPharm AG in Zurich for an interview. We talked about the right intuition for molecules with potential, about the ongoing clinical trial and MetrioPharm’s plans for the future
Dr...
A recent study investigates the correlation between chronic inflammation and Alzheimer’s disease.
Foto: © Fotolia
In our last blog entry, our CEO Dr. Wolfgang Brysch replied to the question: “Does MetrioPharm have competition? You can find the full article here. In this article we take a closer look at a drug that has already been tested.
If a patient suffers from an autoimmune disease, for example psoriasis, his physician ...
Almost done – last work on the MetrioPharm annual report
Photo: © Eva Brysch, 2018
You may have noticed it – for a while it was quiet on our blog. The reason is not that we have lost interest in blogging, the reason is June 20, 2018.
On June 20, the 12th Annual General Meeting of MetrioPharm AG will take place in Kloten; on that day a stack of freshly printed annual reports will be ready to inform new and old shareholders about...
Thank you for visiting our new blog. We want to use our first post to answer three important questions about our new MetrioPharm Blog. Here we go:
The word blog is an abbreviation for weblog. In a literal sense, it is an online logbook. In contrast to a traditional corporate website, a blog is sorted chronologically; as in an old-fashioned logbook, you always read the most current entry first...
© MetrioPharm AG 2019
